Cell and Gene Therapy News
Grants support immunotherapy-based treatment for childhood cancer Feb 5, 2014 Two Baylor College of Medicine researchers have received grants from the nonprofit organization Alex’s Lemonade Stand Foundation to advance their immunotherapy-based treatment approaches for childhood cancer.
Activated “killer” T-cells effective against resistant lymphoma Dec 16, 2013 Lab technique helps cells regain ability to attack tumor, according to new research from Baylor College of Medicine.
Center for Cell and Gene Therapy researchers receive V Foundation translational grant Nov 14, 2013 Drs. Gianpietro Dotti, Cliona Rooney and Caridad Martinez received a
$600,000, three-year grant to advance research into the prevention and
treatment of complications associated with stem cell transplantation to
'Off-the-shelf' virus-specific T-cells fight viral infections in stem cell transplant patients May 14, 2013 Baylor College of Medicine researchers find a potential treatment for patients for whom antiviral drugs are not working.
Gene activity studies classify response to flu vaccine Apr 7, 2013 BCM researchers look to genes to understand flu vaccine effectiveness.
Center for Cell and Gene Therapy receives renewed NIH funding to enhance T cell therapy for cancer Feb 27, 2013 Funding will help advance T cell therapy for kids and adults with cancer, reach wider spectrum of cancers.
Protein inhibitors studied as new cholesterol treatments Feb 19, 2013 BCM researchers are studying new treatments, including a genetic therapy, that may potentially help those with high cholesterol.
Rebuilding blood vessels through gene therapy Dec 20, 2012 Study give insight into safety, effectiveness of gene therapy to rebuild blood vessels in patients living with coronary artery disease.
BCM's Gottschalk receives NIH transformative research award Sep 27, 2012 Award supports work to discover new ways to mobilize the immune system to kill cancer cells.
BCM launches Cancer Exome Sequencing test Sep 4, 2012 Cancer exome sequencing will provide a comprehensive profile of acquired mutations in tumor tissue.